Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

Recruiting now

Conditions studied: Monkeypox

In brief

This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.

Key facts

Study ID

NCT05562323

Run by

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

People needed

100

Starts

2022-09-14

Expected to finish

2026-08-01

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult individuals of ≥18 years old.
• Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.
• Has understood the information provided and capable of giving informed consent.

You may not qualify if…

• Participant has any medical condition and/or finding that in the investigator opinion might increase participant risks, interfere with the study or impair interpretation of study data.

Where it is running

• Germans Trias i Pujol Hospital — Badalona, Barcelona, Spain (enrolling)
• BCN Checkpoint — Barcelona, Barcelona, Spain (enrolling)
• VALLE HEBRÓN HOSPITAL/Centro Salud Internacional y Enfermedades Transmisibles Drassanes — Barcelona, Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.